Enhancing GD2 CAR T-cell therapy with IGF-1R blockade: Are DIPG CAR T cells ready for combinatorial therapy?

Neuro Oncol. 2022 Jul 1;24(7):1164-1165. doi: 10.1093/neuonc/noac073.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Glioma*
  • Humans
  • Immunotherapy, Adoptive
  • Receptor, IGF Type 1
  • Receptors, Chimeric Antigen*
  • T-Lymphocytes

Substances

  • IGF1R protein, human
  • Receptor, IGF Type 1
  • Receptors, Chimeric Antigen